Skip to content

Clinical trials

Phase 3 Cardiovascular Diseases trials in Argentina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 3 Country / region: Argentina Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20062
20073
20083
20092
20104
20112
20123
20132
20141
20161
20171
20181
20193
20234
20242
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Terminated7
Active, not recruiting5
Recruiting4
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Novartis Pharmaceuticals6
Eli Lilly and Company5
GlaxoSmithKline4
Takeda4
Pfizer2
Sanofi2
United Therapeutics2
Alnylam Pharmaceuticals1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases42
Diabetes Mellitus, Type 210
Hypertension9
Myocardial Infarction9
Stroke8
Atherosclerosis6
Heart Diseases6
Heart Failure5
Acute Coronary Syndrome4
Diabetes Mellitus4

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.